1[1] Amann K,Gharehbaghi H,Stephen S,et al. Hypertrophy and hyperplasia of smooth muscle cells of small intramyocardial arteries in spontaneously hypertensive rats[J]. Hypertension,1995,25(1):124.
2[2] Hamet P,Hadrava V,Kruppa U,et al. Transforming growth factor β1 expression and effect in aortic smooth muscle cells from spontaneously hypertensive rats[J]. Hypertension,1991,17(6pt2):896.
3[3] Hadrava V,Kruppa U,Russo RC,et al. Vascular smooth muscle cell proliferation and therapeutic modification in hypertension[J]. Am Heart J,1991,122(4pt2):1198.
4[4] Uehara Y,Numabe A,Kawabata Y,et al. Rapid smooth muscle cell growth and endogenous prostaglandin system in spontaneously hypertensive rats[J]. Am J Hypertens,1991,4:806.
5[5] Saltis J,Agrotis A,Bobik A,Differences in growth characteristics of vascular smooth nuscle cell from spontaneously hypertensive and Wistar-Kyoto rats are growth factor dependent[J]. J Hypertens,1993,11(6):629.
6[6] Kitame Y,Inui H,Uno S,et al. Molecular Structure and transcriptional regulation of the gene for the platelet-derived growth factor receptor in cultured vascular smooth muscle cells[J]. J Clin Invest,1995,96(1):558.
7[7] Fukuda N,Kubo A,Watanabe Y,et al. Antisense oligodeoxynucleotide complementary to platelet-derived growth factor A-chain messenger RNA inhibits the arterial proliferation in spontaneously hypertensive rats without altering their blood pressures[J]. J Hypertens,1997,15(10):1123.
8[8] Fukuda N,Kishioka H,Satoh C,et al. Role of long-form PDGF A-chain in the growth of vascular smooth muslce cells from spontaneously hypertensive rats[J]. Am J Hypertens,1997,10(10pt1):1117.
9[9] Mikhail N,Fukuda N,Tremblay J,et al. Platelets,growth factors,and vascular muscle cells in hypertension and diabetes[J]. J Cardiovasc Pharmacol,1993,22(suppl.6):s64.
10[10] Agrotis A,Saltis J,Bobik A. Transforming growth factor-β1 gene activation and growth of smooth muscle from hypertensive rats[J]. Hypertension,1994,23(5):593.
2O'Donnell AB,Araujo AB,McKinlay JB. The health of normally aging men:The Massachusetts Male Aging Study (1987-2004)[J].{H}Experimental Gerontology,2004,(7):975-984.
3Doumas M,Tsakiris A,Douma S. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects[J].{H}Journal of Andrology,2006,(3):469-477.
4Srilatha B,Adaikan PG,Moore PK. Possible role for the novel gasotransmitter hydrogen sulphide in erectile dysfunction:A pilot study[J].{H}EUROPEAN JOURNAL OF PHARMACOLOGY,2006,(1-3):280-282.
5Anuar F,Whiteman M,Siau JL. Nitric oxide-releasing flurbiprofen reduces formation of proinflammatory hydrogen sulfide in lipopolysaccharide-treated rat[J].Br J Phamacol,2006,(8):966-974.
6Mittawae B,E1-Nashanr AR,Fouda A. Incidence of erectile dysfunction in 800 hypertensive patients:A multieenter Egyptian national study[J].{H}UROLOGY,2006,(3):575-578.
7Wang K,Ahmad S,Cai M. Dysregulation of hydrogen sulfide (H2S) producing enzyme cystathionine γ-lyase (CSE) contributes to maternal hypertension and placental abnormalities in preeclampsia[J].{H}CIRCULATION,2013,(25):2514-2522.
8Chertok VM,Kotsiuba AE. Immunocytochemical characterization H2S-positive neurons in the nuclei of bulbar cardiovascular center in the development of renovascular hypertension[J].{H}Vestnik Rossiiskoi Akademii Meditsinskikh Nauk,2012,(4):50-54.
9Ahmad FU,Sattar MA,Rathore HA. Exogenous hydrogen sulfide (H2S) reduces blood pressure and prevents the progression of diabetic nephropathy in spontaneously hypertensive rats[J].{H}Renal Failure,2012,(2):203-210.
10Brayden JE. Functional role of KATP channels in vascular smooth muscle[J].{H}Clinical and Experimental Pharmacology & Physiology,2002,(4):312-316.
